All news

C4 Therapeutics grants new hire 85,480 options

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

C4 Therapeutics (Nasdaq: CCCC) disclosed an inducement grant of non-qualified stock options covering 85,480 common shares to a newly hired employee. The options carry an exercise price equal to the closing price on the grant date and vest over four years, with 25% vesting on the first anniversary and the remaining 36 equal monthly installments contingent on continued employment.

Read original source

CCCC company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.